BSX vs CPHI · P/E 20, rev $16.75B vs rev $4.1M
Boston Scientific Corp (BSX) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the BSX and CPHI stock pages for the full models.
Not investment advice.